Obesity-Related Glomerulopathy in China: A Case Series of 90 Patients

American Journal of Kidney Diseases

Volumn 52, Issue 1, 2008, Pages 58-65

  Chen, Hui Mei ^a   Li, Shi Jun ^a   Chen, Hui Ping ^a   Wang, Qing Wen ^a   Li, Lei Shi ^a   Liu, Zhi Hong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Chinese population; epidemiology study; obesity; Obesity related glomerulopathy

Indexed keywords

CREATININE; PROTEIN;

ADULT; ARTICLE; BODY MASS; CHINA; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; FEMALE; FOCAL GLOMERULOSCLEROSIS; FREQUENCY ANALYSIS; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; OBESITY RELATED GLOMERULOPATHY; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; BODY MASS INDEX; CHINA; COHORT STUDIES; COMORBIDITY; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; OBESITY; PROBABILITY; PROTEINURIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 45449083054     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.02.303     Document Type: Article

References (26)

1. Gu D., Reynolds K., Wu X., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
2. Saw S.M., and Rajan U. The epidemiology of obesity: A review. Ann Acad Med Singapore 26 (1997) 489-493
3. Rutkowski P., Klassen A., Sebekova K., Bahner U., and Heidland A. Renal disease in obesity: The need for greater attention. J Ren Nutr 16 (2006) 216-223
4. Wahba I.M., and Mak R.H. Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2 (2007) 550-562
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. Zhou B.F., and Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-Study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15 (2002) 83-96
7. Li L.S., and Liu Z.H. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int 66 (2004) 920-923
8. Saxena A.K., and Chopra R. Renal risks of an emerging "epidemic" of obesity: The role of adipocyte-derived factors. Dial Transplant 33 (2004) 11-20
9. Kambham N., Markowitz G.S., Valeri A.M., Lin J., and D'Agati V.D. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59 (2001) 1498-1509
10. Chen H., Liu Z.H., Zeng C.H., Li S.J., Wang Q.W., and Li L.S. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 48 (2006) 772-779
11. Praga M., Hernandez E., Morales E., et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 16 (2001) 1790-1798
12. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
13. Lemann J., Bidani A.K., Bain R.P., Lewis E.J., and Rohde R.D. Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 16 (1990) 236-243
14. Chen Y., Liu Z., Chen H., Jia Z., Wang Q.W., and Li L. Assessment of insulin resistance in patients with obesity related glomerulopathy. Chin Nephrol Dial Transplant 14 (2005) 423-426
15. Kobayashi J., Sasaki T., and Mitsuyo W. The relationship of abdominal fat mass assessed by helical or conventional computed tomography to serum leptin concentration. J Atheroscler Thromb 11 (2004) 173-179
16. Lane P.H., Steffes M.W., and Mauer S.M. Estimation of glomerular volume: A comparison of four methods. Kidney Int 41 (1992) 1085-1089
17. Dalla Vestra M., Masiero A., Roiter A.M., Saller A., Crepaldi G., and Fioretto P. Is podocyte injury relevant in diabetic nephropathy?. Studies in patients with type 2 diabetes. Diabetes 52 (2003) 1031-1035
18. Van den Berg J.G., van den Bergh Weerman M.A., Assmann K.J., Weening J.J., and Florquin S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66 (2004) 1901-1906
19. Popkin B.M., and Doak C.M. The obesity epidemic is a worldwide phenomenon. Nutr Rev 56 (1998) 106-114
20. Deurenberg P., Yap M., and van Staveren W.A. Body mass index and percent body fat: A meta analysis among different ethnic groups. Int J Obes 22 (1998) 1164-1171
21. Lahmann P.H., Lissner L., Gullberg B., and Berglund G. Differences in body fat and central adiposity between Swedes and European immigrants: The Malmo Diet and Cancer Study. Obes Res 8 (2000) 620-631
22. Prage M. Obesity-A neglected culprit in renal disease. Nephrol Dial Transplant 17 (2002) 1157-1159
23. Chen H., Liu Z.H., Li S.J., et al. The relationship between body fat distribution and renal damage in Chinese with obesity. Exp Clin Endocrinol Diabetes 116 (2008) 99-103
24. Ramirez S.Y., Mcclellan W., Port F.K., and Hsu S.H. Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 13 (2002) 1907-1917
25. Praga M., Morales E., Herrero J., et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 33 (1999) 52-58
26. Sowers J.R. Metabolic risk factors and renal disease. Kidney Int 71 (2007) 719-720